According to Altimmune's latest financial reports the company's current revenue (TTM ) is A$0.03 Million. a decrease over the revenue in the year 2023 that were of A$0.62 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | A$0.03 M | -94.86% |
2023 | A$0.62 M | -725.74% |
2022 | -A$0.1 Million | -101.64% |
2021 | A$6.08 M | -42.85% |
2020 | A$10.64 M | 28.47% |
2019 | A$8.28 M | -67.68% |
2018 | A$25.63 M | 48120.39% |
2017 | A$0.05 M | -98.33% |
2016 | A$3.17 M | -78.26% |
2015 | A$14.6 M | 17.31% |
2014 | A$12.45 M | -38% |
2013 | A$20.08 M | -17.11% |
2012 | A$24.22 M | 2.37% |
2011 | A$23.66 M | 14.51% |
2010 | A$20.66 M | -32.61% |
2009 | A$30.66 M | -34.26% |
2008 | A$46.64 M | 180.26% |
2007 | A$16.64 M | 861.39% |
2006 | A$1.73 M |